<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37011055</PMID><DateCompleted><Year>2023</Year><Month>08</Month><Day>31</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>04</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2326-5205</ISSN><JournalIssue CitedMedium="Internet"><Volume>75</Volume><Issue>9</Issue><PubDate><Year>2023</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Arthritis &amp; rheumatology (Hoboken, N.J.)</Title><ISOAbbreviation>Arthritis Rheumatol</ISOAbbreviation></Journal><ArticleTitle>Higher Genetic Risk Loads Confer More Diverse Manifestations and Higher Risk of Lupus Nephritis in Systemic Lupus Erythematosus.</ArticleTitle><Pagination><StartPage>1566</StartPage><EndPage>1572</EndPage><MedlinePgn>1566-1572</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/art.42516</ELocationID><Abstract><AbstractText Label="OBJECTIVE">Systemic lupus erythematosus (SLE) is a highly heritable complex disorder with heterogeneous clinical manifestations. In this study, we aimed to identify the genetic risk load using clinical and serological manifestations in SLE patients.</AbstractText><AbstractText Label="METHODS">We genotyped a total of 1,655 Korean patients with SLE (n&#xa0;=&#xa0;1,243 as a discovery set and n&#xa0;=&#xa0;412 as a replication set) using a customized genome-wide single-nucleotide polymorphism (SNP) array, KoreanChip. A weighted genetic risk score (wGRS) for an individual was calculated from 112 well-validated non-HLA SNPs and HLA haplotypes of SLE-risk loci. We analyzed associations between individual wGRS and clinical SLE subphenotypes and autoantibodies using multivariable linear or logistic regression adjusted by onset age, sex, and disease duration.</AbstractText><AbstractText Label="RESULTS">Childhood-onset SLE (&lt;16&#x2009;years) conferred the highest genetic risk compared with adult-onset (16-50&#x2009;years) or late-onset (&gt;50&#x2009;years) SLE (P =&#x2009;6.8 &#xd7;&#x2009;10<sup>-6</sup> ). High wGRS significantly increased associations with SLE manifestations, regardless of onset age, sex, and disease duration. Individual wGRS significantly correlated positively with more clinical American College of Rheumatology criteria (&#x3b2;&#xa0;=&#xa0;0.143, P =&#x2009;1.8 &#xd7;&#x2009;10<sup>-6</sup> ). Subphenotype analysis revealed significant associations between the highest and lowest wGRS quartile with risk of renal disorder (hazard ratio [HR] 1.74, P =&#x2009;2.2 &#xd7;&#x2009;10<sup>-8</sup> ) and anti-Sm antibody production (HR 1.85, P =&#x2009;2.8 &#xd7;&#x2009;10<sup>-5</sup> ). Higher wGRS markedly modulated the pathogenesis of proliferative and membranous lupus nephritis class III or IV (HR 1.98, P =&#x2009;1.6 &#xd7;&#x2009;10<sup>-5</sup> ) and class V (HR 2.79, P =&#x2009;1.0 &#xd7;&#x2009;10<sup>-3</sup> ), but especially lupus nephritis class V in anti-Sm-positive SLE (area under the curve 0.68, P =&#x2009;1.8 &#xd7;&#x2009;10<sup>-4</sup> ).</AbstractText><AbstractText Label="CONCLUSION">Patients with SLE and high wGRS tended to have earlier age of SLE onset, higher anti-Sm antibody positivity, and more diverse clinical phenotypes. Genetic profiling may predict high risk for lupus nephritis and a diverse clinical course in SLE patients.</AbstractText><CopyrightInformation>&#xa9; 2023 American College of Rheumatology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kwon</LastName><ForeName>Young-Chang</ForeName><Initials>YC</Initials><AffiliationInfo><Affiliation>Hanyang University Institute for Rheumatology Research and Hanyang Institute of Bioscience and Biotechnology, Hanyang University, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ha</LastName><ForeName>Eunji</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Biology and Department of Life and Nanopharmaceutical Sciences, Kyung Hee University, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kwon</LastName><ForeName>Hyuk-Hee</ForeName><Initials>HH</Initials><AffiliationInfo><Affiliation>Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Dae Jin</ForeName><Initials>DJ</Initials><AffiliationInfo><Affiliation>Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shin</LastName><ForeName>Jung-Min</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Joo</LastName><ForeName>Young Bin</ForeName><Initials>YB</Initials><Identifier Source="ORCID">0000-0001-5580-8996</Identifier><AffiliationInfo><Affiliation>Hanyang University Institute for Rheumatology Research and Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chung</LastName><ForeName>Won Tae</ForeName><Initials>WT</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, College of Medicine, Dong-A University, Pusan, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yoo</LastName><ForeName>Dae-Hyun</ForeName><Initials>DH</Initials><AffiliationInfo><Affiliation>Hanyang University Institute for Rheumatology Research and Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Hye-Soon</ForeName><Initials>HS</Initials><Identifier Source="ORCID">0000-0002-8535-0442</Identifier><AffiliationInfo><Affiliation>Hanyang University Institute for Rheumatology Research, Seoul, Republic of Korea; Hanyang Institute of Bioscience and Biotechnology, Hanyang University, Seoul, Republic of Korea; and Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Kwangwoo</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0001-8926-6216</Identifier><AffiliationInfo><Affiliation>Department of Biology and Department of Life and Nanopharmaceutical Sciences, Kyung Hee University, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bae</LastName><ForeName>Sang-Cheol</ForeName><Initials>SC</Initials><Identifier Source="ORCID">0000-0003-4658-1093</Identifier><AffiliationInfo><Affiliation>Hanyang University Institute for Rheumatology Research, Seoul, Republic of Korea; Hanyang Institute of Bioscience and Biotechnology, Hanyang University, Seoul, Republic of Korea; and Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bang</LastName><ForeName>So-Young</ForeName><Initials>SY</Initials><Identifier Source="ORCID">0000-0003-4699-9350</Identifier><AffiliationInfo><Affiliation>Hanyang University Institute for Rheumatology Research, Seoul, Republic of Korea; Hanyang Institute of Bioscience and Biotechnology, Hanyang University, Seoul, Republic of Korea; and Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>06</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Arthritis Rheumatol</MedlineTA><NlmUniqueID>101623795</NlmUniqueID><ISSNLinking>2326-5191</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001323">Autoantibodies</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008181" MajorTopicYN="Y">Lupus Nephritis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005838" MajorTopicYN="N">Genotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001323" MajorTopicYN="N">Autoantibodies</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>3</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>3</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>31</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>3</Day><Hour>14</Hour><Minute>4</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37011055</ArticleId><ArticleId IdType="doi">10.1002/art.42516</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Liu Z, Davidson A. Taming lupus-a new understanding of pathogenesis is leading to clinical advances. Nat Med 2012;18:871-82.</Citation></Reference><Reference><Citation>Yin X, Kim K, Suetsugu H, et al. Meta-analysis of 208370 East Asians identifies 113 susceptibility loci for systemic lupus erythematosus. Ann Rheum Dis 2021;80:632-40.</Citation></Reference><Reference><Citation>Lewis MJ, Jawad AS. The effect of ethnicity and genetic ancestry on the epidemiology, clinical features and outcome of systemic lupus erythematosus. Rheumatology (Oxford) 2017;56:i67-77.</Citation></Reference><Reference><Citation>Joo YB, Lim J, Tsao BP, et al. Genetic variants in systemic lupus erythematosus susceptibility loci, XKR6 and GLT1D1 are associated with childhood-onset SLE in a Korean cohort. Sci Rep 2018;8:9962.</Citation></Reference><Reference><Citation>Reid S, Alexsson A, Frodlund M, et al. High genetic risk score is associated with early disease onset, damage accrual and decreased survival in systemic lupus erythematosus. Ann Rheum Dis 2020;79:363-9.</Citation></Reference><Reference><Citation>Joo YB, Bae SC. Assessment of clinical manifestations, disease activity and organ damage in 996 Korean patients with systemic lupus erythematosus: comparison with other Asian populations. Int J Rheum Dis 2015;18:117-28.</Citation></Reference><Reference><Citation>Hochberg MC, for the Diagnostic and Therapeutic Criteria Committee of the American College of Rheumatology. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [letter]. Arthritis Rheum 1997;40:1725.</Citation></Reference><Reference><Citation>Petri M, Orbai AM, Alarc&#xf3;n GS, et al. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum 2012;64:2677-86.</Citation></Reference><Reference><Citation>Bajema IM, Wilhelmus S, Alpers CE, et al. Revision of the International Society of Nephrology/Renal Pathology Society classification for lupus nephritis: clarification of definitions, and modified National Institutes of Health activity and chronicity indices. Kidney Int 2018;93:789-96.</Citation></Reference><Reference><Citation>Moon S, Kim YJ, Han S, et al. The Korea Biobank Array: design and identification of coding variants associated with blood biochemical traits. Sci Rep 2019;9:1382.</Citation></Reference><Reference><Citation>Bycroft C, Freeman C, Petkova D, et al. The UK Biobank resource with deep phenotyping and genomic data. Nature 2018;562:203-9.</Citation></Reference><Reference><Citation>Kim K, Bang SY, Lee HS, et al. The HLA-DR&#x3b2;1 amino acid positions 11-13-26 explain the majority of SLE-MHC associations. Nat Commun 2014;5:5902.</Citation></Reference><Reference><Citation>Dudbridge F. Power and predictive accuracy of polygenic risk scores. PLoS Genet 2013;9:e1003348.</Citation></Reference><Reference><Citation>Chen L, Wang YF, Liu L, et al. Genome-wide assessment of genetic risk for systemic lupus erythematosus and disease severity. Hum Mol Genet 2020;29:1745-56.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>